In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 16th, 2009 | 34 | No |
Popular Name: Canertinib Canertinib
Find On: PubMed — Wikipedia — Google
CAS Numbers: 267243-28-7 , 267543-28-7 , 289499-45-2 , [267243-28-7] , [289499-45-2]
289499-45-2; Canertinib dihydrochloride (USAN); D03350
Canertinib (INN); Canertinib Dihydrochloride (USAN)
Canertinib dihydrochloride (USAN)
Canertinib dihydrochloride [USAN]
Canertinib, PD-183805, CI1033, PD183805
CI-1033; PD-0183805; PD-183805
CI-1033; PD-0183805; PD-183805; SN-26606
N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide
N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide
N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide
N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.35 | 8.5 | -12.22 | 2 | 8 | 0 | 89 | 485.947 | 9 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | EGFR, HER2 | Selleck Chemicals |
Reactome Database Links | REACT_115744; REACT_116096 | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 730 | 0.25 | Binding ≤ 10μM |
ABL2-1-E | Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 870 | 0.25 | Binding ≤ 10μM |
ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.24 | Binding ≤ 10μM |
ADCK3-1-E | Chaperone Activity Of Bc1 Complex-like, Mitochondrial (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.24 | Binding ≤ 10μM |
ADCK4-1-E | Uncharacterized AarF Domain-containing Protein Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3400 | 0.23 | Binding ≤ 10μM |
AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4200 | 0.22 | Binding ≤ 10μM |
AURKC-1-E | Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3500 | 0.22 | Binding ≤ 10μM |
BLK-1-E | Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 50 | 0.30 | Binding ≤ 10μM |
BMP2K-1-E | BMP-2-inducible Protein Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3800 | 0.22 | Binding ≤ 10μM |
BMX-1-E | Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic | Eukaryotes | 62 | 0.30 | Binding ≤ 10μM |
BTK-1-E | Tyrosine-protein Kinase BTK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 750 | 0.25 | Binding ≤ 10μM |
CSK-1-E | Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6100 | 0.21 | Binding ≤ 10μM |
CTRO-1-E | Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.24 | Binding ≤ 10μM |
DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.26 | Binding ≤ 10μM |
EGFR-3-E | Epidermal Growth Factor Receptor ErbB1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 7 | 0.34 | Binding ≤ 10μM |
EPHA1-1-E | Ephrin Type-A Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.23 | Binding ≤ 10μM |
EPHA3-1-E | Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 650 | 0.25 | Binding ≤ 10μM |
EPHA4-1-E | Ephrin Type-A Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3600 | 0.22 | Binding ≤ 10μM |
EPHA5-1-E | Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 270 | 0.27 | Binding ≤ 10μM |
EPHA6-1-E | Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 72 | 0.29 | Binding ≤ 10μM |
EPHA7-1-E | Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.24 | Binding ≤ 10μM |
EPHA8-1-E | Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 790 | 0.25 | Binding ≤ 10μM |
EPHB1-1-E | Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.24 | Binding ≤ 10μM |
EPHB2-1-E | Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2700 | 0.23 | Binding ≤ 10μM |
EPHB4-1-E | Ephrin Type-B Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.22 | Binding ≤ 10μM |
ERBB2-2-E | Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 9 | 0.33 | Binding ≤ 10μM |
ERBB4-1-E | Receptor Protein-tyrosine Kinase ErbB-4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 31 | 0.31 | Binding ≤ 10μM |
FGR-1-E | Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2800 | 0.23 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 730 | 0.25 | Binding ≤ 10μM |
FRK-1-E | Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8100 | 0.21 | Binding ≤ 10μM |
GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 44 | 0.30 | Binding ≤ 10μM |
HCK-1-E | Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5700 | 0.22 | Binding ≤ 10μM |
IRAK3-1-E | Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.23 | Binding ≤ 10μM |
ITK-1-E | Tyrosine-protein Kinase ITK/TSK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5650 | 0.22 | Binding ≤ 10μM |
JAK3-1-E | Tyrosine-protein Kinase JAK3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 630 | 0.26 | Binding ≤ 10μM |
KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7900 | 0.21 | Binding ≤ 10μM |
KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.21 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 560 | 0.26 | Binding ≤ 10μM |
LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 810 | 0.25 | Binding ≤ 10μM |
M3K4-1-E | Mitogen-activated Protein Kinase Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8400 | 0.21 | Binding ≤ 10μM |
M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2600 | 0.23 | Binding ≤ 10μM |
MET-1-E | Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5600 | 0.22 | Binding ≤ 10μM |
MK06-1-E | Mitogen-activated Protein Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.24 | Binding ≤ 10μM |
MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1100 | 0.25 | Binding ≤ 10μM |
MK10-1-E | C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5500 | 0.22 | Binding ≤ 10μM |
MKNK1-1-E | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 260 | 0.27 | Binding ≤ 10μM |
MKNK2-1-E | MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.24 | Binding ≤ 10μM |
MLTK-1-E | Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.24 | Binding ≤ 10μM |
MP2K1-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1800 | 0.24 | Binding ≤ 10μM |
MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.24 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5200 | 0.22 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7500 | 0.21 | Binding ≤ 10μM |
PTK6-1-E | Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3800 | 0.22 | Binding ≤ 10μM |
RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 840 | 0.25 | Binding ≤ 10μM |
RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 330 | 0.27 | Binding ≤ 10μM |
SIK2-1-E | Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4900 | 0.22 | Binding ≤ 10μM |
SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 440 | 0.26 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 760 | 0.25 | Binding ≤ 10μM |
SRMS-1-E | Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6700 | 0.21 | Binding ≤ 10μM |
ST17A-1-E | Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3800 | 0.22 | Binding ≤ 10μM |
STK10-1-E | Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 430 | 0.26 | Binding ≤ 10μM |
STK36-1-E | Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4500 | 0.22 | Binding ≤ 10μM |
TBA1A-1-E | Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic | Eukaryotes | 29 | 0.31 | Binding ≤ 10μM |
TEC-1-E | Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.24 | Binding ≤ 10μM |
TESK1-1-E | Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3200 | 0.23 | Binding ≤ 10μM |
TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9600 | 0.21 | Binding ≤ 10μM |
TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 800 | 0.25 | Binding ≤ 10μM |
TIE1-1-E | Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.23 | Binding ≤ 10μM |
TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5600 | 0.22 | Binding ≤ 10μM |
TXK-1-E | Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 700 | 0.25 | Binding ≤ 10μM |
TYRO3-1-E | Tyrosine-protein Kinase Receptor TYRO3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.25 | Binding ≤ 10μM |
UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5700 | 0.22 | Binding ≤ 10μM |
YES-1-E | Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.23 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2 | 0.36 | Functional ≤ 10μM |
ERBB2-2-E | Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 7 | 0.34 | Functional ≤ 10μM |
Z80961-1-O | HN5 (Squamous Cell Carcinoma) (cluster #1 Of 1), Other | Other | 50 | 0.30 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 650 | 0.25 | Binding ≤ 1μM |
EPHA4_HUMAN | P54764 | Ephrin Type-A Receptor 4, Human | 310 | 0.27 | Binding ≤ 1μM |
EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 270 | 0.27 | Binding ≤ 1μM |
EPHA6_HUMAN | Q9UF33 | Ephrin Type-A Receptor 6, Human | 270 | 0.27 | Binding ≤ 1μM |
EPHA8_HUMAN | P29322 | Ephrin Type-A Receptor 8, Human | 790 | 0.25 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 0.13 | 0.41 | Binding ≤ 1μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 400 | 0.26 | Binding ≤ 1μM |
MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 260 | 0.27 | Binding ≤ 1μM |
ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 48 | 0.30 | Binding ≤ 1μM |
ERBB4_HUMAN | Q15303 | Receptor Protein-tyrosine Kinase ErbB-4, Human | 14 | 0.32 | Binding ≤ 1μM |
STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 430 | 0.26 | Binding ≤ 1μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 440 | 0.26 | Binding ≤ 1μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 100 | 0.29 | Binding ≤ 1μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 300 | 0.27 | Binding ≤ 1μM |
TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 800 | 0.25 | Binding ≤ 1μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 29 | 0.31 | Binding ≤ 1μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 1000 | 0.25 | Binding ≤ 1μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 870 | 0.25 | Binding ≤ 1μM |
BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 29 | 0.31 | Binding ≤ 1μM |
BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 586 | 0.26 | Binding ≤ 1μM |
BTK_HUMAN | Q06187 | Tyrosine-protein Kinase BTK, Human | 185 | 0.28 | Binding ≤ 1μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 630 | 0.26 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 320 | 0.27 | Binding ≤ 1μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 780 | 0.25 | Binding ≤ 1μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 730 | 0.25 | Binding ≤ 1μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 840 | 0.25 | Binding ≤ 1μM |
TYRO3_HUMAN | Q06418 | Tyrosine-protein Kinase Receptor TYRO3, Human | 1000 | 0.25 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 760 | 0.25 | Binding ≤ 1μM |
TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 700 | 0.25 | Binding ≤ 1μM |
ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 1700 | 0.24 | Binding ≤ 10μM |
BMP2K_HUMAN | Q9NSY1 | BMP-2-inducible Protein Kinase, Human | 1600 | 0.24 | Binding ≤ 10μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 1100 | 0.25 | Binding ≤ 10μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 2800 | 0.23 | Binding ≤ 10μM |
ADCK3_HUMAN | Q8NI60 | Chaperone Activity Of Bc1 Complex-like, Mitochondrial, Human | 1500 | 0.24 | Binding ≤ 10μM |
CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 1300 | 0.24 | Binding ≤ 10μM |
MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 1800 | 0.24 | Binding ≤ 10μM |
MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 1600 | 0.24 | Binding ≤ 10μM |
TESK1_HUMAN | Q15569 | Dual Specificity Testis-specific Protein Kinase 1, Human | 3200 | 0.23 | Binding ≤ 10μM |
EPHA1_HUMAN | P21709 | Ephrin Type-A Receptor 1, Human | 2500 | 0.23 | Binding ≤ 10μM |
EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 2100 | 0.23 | Binding ≤ 10μM |
EPHA4_HUMAN | P54764 | Ephrin Type-A Receptor 4, Human | 310 | 0.27 | Binding ≤ 10μM |
EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 1200 | 0.24 | Binding ≤ 10μM |
EPHA6_HUMAN | Q9UF33 | Ephrin Type-A Receptor 6, Human | 270 | 0.27 | Binding ≤ 10μM |
EPHA7_HUMAN | Q15375 | Ephrin Type-A Receptor 7, Human | 1500 | 0.24 | Binding ≤ 10μM |
EPHA8_HUMAN | P29322 | Ephrin Type-A Receptor 8, Human | 2000 | 0.23 | Binding ≤ 10μM |
EPHB1_HUMAN | P54762 | Ephrin Type-B Receptor 1, Human | 1400 | 0.24 | Binding ≤ 10μM |
EPHB2_HUMAN | P29323 | Ephrin Type-B Receptor 2, Human | 2700 | 0.23 | Binding ≤ 10μM |
EPHB4_HUMAN | P54760 | Ephrin Type-B Receptor 4, Human | 1800 | 0.24 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 0.13 | 0.41 | Binding ≤ 10μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 400 | 0.26 | Binding ≤ 10μM |
MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 5600 | 0.22 | Binding ≤ 10μM |
IRAK3_HUMAN | Q9Y616 | Interleukin-1 Receptor-associated Kinase 3, Human | 3000 | 0.23 | Binding ≤ 10μM |
MKNK2_HUMAN | Q9HBH9 | MAP Kinase Signal-integrating Kinase 2, Human | 1300 | 0.24 | Binding ≤ 10μM |
MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 260 | 0.27 | Binding ≤ 10μM |
MK06_HUMAN | Q16659 | Mitogen-activated Protein Kinase 6, Human | 1700 | 0.24 | Binding ≤ 10μM |
M3K4_HUMAN | Q9Y6R4 | Mitogen-activated Protein Kinase Kinase Kinase 4, Human | 2000 | 0.23 | Binding ≤ 10μM |
M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 1300 | 0.24 | Binding ≤ 10μM |
MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 1200 | 0.24 | Binding ≤ 10μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 5200 | 0.22 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 7500 | 0.21 | Binding ≤ 10μM |
ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 48 | 0.30 | Binding ≤ 10μM |
ERBB4_HUMAN | Q15303 | Receptor Protein-tyrosine Kinase ErbB-4, Human | 14 | 0.32 | Binding ≤ 10μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 6200 | 0.21 | Binding ≤ 10μM |
STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 1900 | 0.24 | Binding ≤ 10μM |
ST17A_HUMAN | Q9UEE5 | Serine/threonine-protein Kinase 17A, Human | 3800 | 0.22 | Binding ≤ 10μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 1800 | 0.24 | Binding ≤ 10μM |
STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 2700 | 0.23 | Binding ≤ 10μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 4200 | 0.22 | Binding ≤ 10μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 2800 | 0.23 | Binding ≤ 10μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 100 | 0.29 | Binding ≤ 10μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 300 | 0.27 | Binding ≤ 10μM |
SIK2_HUMAN | Q9H0K1 | Serine/threonine-protein Kinase SIK2, Human | 4900 | 0.22 | Binding ≤ 10μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 5600 | 0.22 | Binding ≤ 10μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 3900 | 0.22 | Binding ≤ 10μM |
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 9600 | 0.21 | Binding ≤ 10μM |
TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 800 | 0.25 | Binding ≤ 10μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 29 | 0.31 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 1000 | 0.25 | Binding ≤ 10μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 1300 | 0.24 | Binding ≤ 10μM |
BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 29 | 0.31 | Binding ≤ 10μM |
BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 1200 | 0.24 | Binding ≤ 10μM |
PTK6_HUMAN | Q13882 | Tyrosine-protein Kinase BRK, Human | 1100 | 0.25 | Binding ≤ 10μM |
BTK_HUMAN | Q06187 | Tyrosine-protein Kinase BTK, Human | 1600 | 0.24 | Binding ≤ 10μM |
CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 2900 | 0.23 | Binding ≤ 10μM |
FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 1700 | 0.24 | Binding ≤ 10μM |
FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 3400 | 0.23 | Binding ≤ 10μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 4200 | 0.22 | Binding ≤ 10μM |
ITK_HUMAN | Q08881 | Tyrosine-protein Kinase ITK/TSK, Human | 5600 | 0.22 | Binding ≤ 10μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 2000 | 0.23 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 320 | 0.27 | Binding ≤ 10μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 780 | 0.25 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1200 | 0.24 | Binding ≤ 10μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 4200 | 0.22 | Binding ≤ 10μM |
TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 2200 | 0.23 | Binding ≤ 10μM |
TYRO3_HUMAN | Q06418 | Tyrosine-protein Kinase Receptor TYRO3, Human | 1000 | 0.25 | Binding ≤ 10μM |
UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 5700 | 0.22 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 1100 | 0.25 | Binding ≤ 10μM |
SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 6700 | 0.21 | Binding ≤ 10μM |
TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 1500 | 0.24 | Binding ≤ 10μM |
TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 700 | 0.25 | Binding ≤ 10μM |
YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 1600 | 0.24 | Binding ≤ 10μM |
ADCK4_HUMAN | Q96D53 | Uncharacterized AarF Domain-containing Protein Kinase 4, Human | 3400 | 0.23 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1.7 | 0.36 | Functional ≤ 10μM |
Z80961 | Z80961 | HN5 (Squamous Cell Carcinoma) | 50 | 0.30 | Functional ≤ 10μM |
ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 529 | 0.26 | Functional ≤ 10μM |
Description | Species |
---|---|
Signaling by constitutively active EGFR |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of the AP-1 family of transcription factors | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
Apoptotic cleavage of cellular proteins | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Cell surface interactions at the vascular wall | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Downregulation of ERBB2:ERBB3 signaling | |
Downregulation of TGF-beta receptor signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK/MAPK targets | |
ERK1 activation | |
ERK2 activation | |
Factors involved in megakaryocyte development and platelet production | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
Formation of tubulin folding intermediates by CCT/TriC | |
GAB1 signalosome | |
Gap junction assembly | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Generation of second messenger molecules | |
Golgi Associated Vesicle Biogenesis | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
GRB7 events in ERBB2 signaling | |
Growth hormone receptor signaling | |
Integrin alphaIIb beta3 signaling | |
Interleukin receptor SHC signaling | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-7 signaling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Kinesins | |
L1CAM interactions | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MEK activation | |
MHC class II antigen presentation | |
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | |
Mitotic Prometaphase | |
MyD88:Mal cascade initiated on plasma membrane | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
NOD1/2 Signaling Pathway | |
Non-integrin membrane-ECM interactions | |
Oxidative Stress Induced Senescence | |
p75NTR recruits signalling complexes | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
Platelet Adhesion to exposed collagen | |
Platelet sensitization by LDL | |
PLCG1 events in ERBB2 signaling | |
Post-chaperonin tubulin folding pathway | |
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | |
Prefoldin mediated transfer of substrate to CCT/TriC | |
RAF phosphorylates MEK | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Resolution of Sister Chromatid Cohesion | |
Role of Abl in Robo-Slit signaling | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
RSK activation | |
Sema4D induced cell migration and growth-cone collapse | |
Sema4D mediated inhibition of cell attachment and migration | |
Senescence-Associated Secretory Phenotype (SASP) | |
Separation of Sister Chromatids | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by FGFR | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
SMAD2/3 MH2 Domain Mutants in Cancer | |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
Spry regulation of FGF signaling | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
TGF-beta receptor signaling activates SMADs | |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
TGFBR1 KD Mutants in Cancer | |
TGFBR1 LBD Mutants in Cancer | |
TGFBR2 Kinase Domain Mutants in Cancer | |
TGFBR2 MSI Frameshift Mutants in Cancer | |
Translocation of GLUT4 to the plasma membrane | |
Translocation of ZAP-70 to Immunological synapse | |
Uptake and function of anthrax toxins | |
VEGFA-VEGFR2 Pathway |